KROMEK GROUP PLC (KMK) — Capital Markets Day Live Q&A Session

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen. Welcome to the KROMEK GROUP PLC Capital Markets Day Q and A session. Throughout today's presentation, investors will be in listen only mode and questions are encouraged. You can submit them at any time just using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions at any time and press send. Before we begin, we'd like to submit the following poll, and I'm sure the company will be most grateful for your participation. And I'd now like to hand over to CEO, Anab Basu. Good afternoon to you. Thank you, Mark. Good afternoon, everybody. Thanks for joining. We had a Capital Markets Day last week, many of you may have seen the recording or on our website. Today, we have me and my colleagues. I'm Anna Basu, the CEO, and my colleagues are here. Claire Birches, our CFO. You'll hear from Claire. Barry Bumer, our president of the advanced imaging segment, will join us from our Pittsburgh facility. And Michael Stephenson, our commercial and strategy director, will be joining us from Poland where he's on a customer visit at the moment. So we'll we'll have a quick sort of recap of what we talked about in the Capital Markets Day. Many of you know the company for a while, and some of you may be new. So and just getting acquainted with the company. So let me give you a very quick introduction to the company. We are a global detection business operating in in the global medical imaging, security, defense, and civil nuclear markets. And and we operate out of four facilities in The UK and The US, manufacturing both in The UK and The and US in in Durham and Pittsburgh, employing just over a 150 people and serving two very large growing markets market segment through two business units. So just a very quick re...